Panel recommends Lilly continue breast cancer drug study - Fox News

Fox News

Panel recommends Lilly continue breast cancer drug study Fox News Eli Lilly and Co said an interim analysis of a late-stage study testing its breast cancer drug abemaciclib by an independent panel showed the treatment did not meet the effectiveness criteria and recommended that the company continue the trial. The ... Lilly Provides Update on MONARCH 2 Phase 3 Trial of AbemaciclibPR Newswire (press release) all 3 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHyS7gV3zuFwTumrSSl-x3mg-tgOg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779177851095&ei=aRWrV4DHEsKi3gHLoY3gDA&url=http://www.foxnews.com/health/2016/08/10/panel-recommends-lilly-continue-breast-cancer-drug-study.html
via IFTTT